Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.

被引：0
|
作者：
Amit Patel
Umeer Waheed
Stephen J. Brett
机构：
[1] Hammersmith Hospital,Centre for Perioperative Medicine and Critical Care Research, General Intensive Care Unit
[2] Imperial College Healthcare NHS Trust,MRC Clinical Sciences Centre and Centre for Haematology
[3] Imperial College London,undefined
[4] Hammersmith Hospital,undefined
来源：
Intensive Care Medicine | 2013年 / 39卷
关键词：
Severe Sepsis; Eligibility Criterion; Primary Outcome Measure; Volume Expansion; Randomise Clinical Trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1507 / 1508
页数：1
相关论文
共 46 条
  • [21] 6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
    Andreas Margraf
    Jan M. Herter
    Katharina Kühne
    Anika Stadtmann
    Thomas Ermert
    Manuel Wenk
    Melanie Meersch
    Hugo Van Aken
    Alexander Zarbock
    Jan Rossaint
    [J]. Critical Care, 22
  • [22] 6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
    Margraf, Andreas
    Herter, Jan M.
    Kuehne, Katharina
    Stadtmann, Anika
    Ermert, Thomas
    Wenk, Manuel
    Meersch, Melanie
    Van Aken, Hugo
    Zarbock, Alexander
    Rossaint, Jan
    [J]. CRITICAL CARE, 2018, 22
  • [23] Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6% or 10% solutions in healthy volunteers
    Waitzinger, J
    Bepperling, F
    Pabst, G
    Opitz, J
    Muller, M
    Baron, JF
    [J]. CLINICAL DRUG INVESTIGATION, 1998, 16 (02) : 151 - 160
  • [24] Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers
    Josef Waitzinger
    Frank Bepperling
    Günther Pabst
    Jens Opitz
    Margarete Müller
    Jean François Baron
    [J]. Clinical Drug Investigation, 1998, 16 : 151 - 160
  • [25] EVALUATION OF THE RISK OF ACUTE KIDNEY INJURY ASSOCIATED WITH THE USE OF HYDROXYETHYL STARCH 130/0.4 (VOLUVEN 6%) IN CARDIAC SURGERY
    Frenette, A. J.
    Bernier, P.
    Charbonneau, A.
    Nguyen, L. T.
    Troyanov, S.
    Rioux, J. P.
    Heylbroeck, C.
    Williamson, D.
    [J]. INTENSIVE CARE MEDICINE, 2011, 37 : S255 - S255
  • [26] The effects of tranexamic acid and 6% hydroxyethyl starch (HES) solution (130/0.4) on postoperative bleeding in coronary artery bypass graft (CABG) surgery
    Yanartas, M.
    Baysal, A.
    Aydin, C.
    Ay, Y.
    Kara, I.
    Aydin, E.
    Cevirme, D.
    Koksal, C.
    Sunar, H.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 5959 - 5971
  • [27] THE EFFECT OF 6% HES (HYDROXYETHYL STARCH) 130/0.4 ON THE CONCENTRATION OF BLOOD POTASSIUM IN ORTHOPEDIC AHD (ACUTE HEMODIULUTION) PATIENTS AND ITS MECHANISM EXPLORATION
    Zhang, Jianzhong
    Dong, Chuanzhen
    Huang, Shaoyan
    Shao, Wei
    Ma, Huashan
    Yan, Yurong
    [J]. ACTA MEDICA MEDITERRANEA, 2020, 36 (02): : 989 - 994
  • [28] Volume replacement during major orthopedic surgery: a new 6% hydroxyethyl starch solution (HES 130/0.4) might reduce blood loss
    Langeron, O
    Hbitz, D
    Faure, E
    Marty, J
    Coriat, P
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 74 - 74
  • [29] Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression
    Ma Peng-Lin
    Peng Xiao-Xia
    Du Bin
    Hu Xiao-Lan
    Gong Yi-Chun
    Wang Yu
    Xi Xiu-Ming
    [J]. 中华医学杂志(英文版), 2015, (17) : 2374 - 2382
  • [30] Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression
    Ma, Peng-Lin
    Peng, Xiao-Xia
    Du, Bin
    Hu, Xiao-Lan
    Gong, Yi-Chun
    Wang, Yu
    Xi, Xiu-Ming
    [J]. CHINESE MEDICAL JOURNAL, 2015, 128 (17) : 2374 - 2382
12345